Extended Release Niacin/Laropiprant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Extended Release Niacin/Laropiprant, covering 2008-11-27 to 2008-11-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED) [Phase 1]